NeuroBo Pharmaceuticals I... (NRBO)
2.36
0.01 (0.43%)
At close: Nov 27, 2024, 9:00 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Net Income | -12.47M | -13.97M | -15.28M | -29.68M | -21.31M | -23.64M | -33.41M | -14.59M | -9.03M | -320.00K |
| Depreciation & Amortization | 6.00K | 20.00K | 48.00K | 46.00K | 17.00K | 346.00K | 137.00K | -17.00K | n/a | n/a |
| Stock-Based Compensation | 222.00K | 854.00 | 662.00 | 699.00 | 118.00 | 4.13M | 5.27M | 1.72M | 284.00K | 53.00K |
| Other Working Capital | 4.28M | -966.00K | 578.00K | -314.00K | 1.79M | -770.00K | -903.00K | 441.00K | 1.00M | 23.00K |
| Other Non-Cash Items | -2.95M | 2.55M | 24.00K | 17.36M | 12.28M | 346.00K | 137.00K | 200.00K | 1.87M | 55.00K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | 1.11M | -346.00K | -137.00K | -276.00K | n/a | n/a |
| Change in Working Capital | 4.40M | -1.17M | -584.00K | 809.00K | 744.00K | -2.75M | 1.10M | 1.92M | 1.45M | 17.00K |
| Operating Cash Flow | -10.80M | -11.71M | -15.13M | -10.76M | -7.04M | -21.91M | -26.90M | -11.04M | -5.43M | -195.00K |
| Capital Expenditures | -50.00K | n/a | -3.00K | -4.00K | -214.00K | -3.00K | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | 8.00K | -583 | 180.00K | 1.52M | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 8.00 | -582.42K | -107.00K | -7.37M | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -50.00K | 8.00K | -586.00K | 69.00K | -6.06M | -3.00K | n/a | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | 500.00K | 10.00M | 5.15M | 7.42M | 509.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -80.00K | -3.57M | -1.97M | -642.00K | 24.17M | -8.40M | -1.20M | -3.97M | 1.32M | n/a |
| Financial Cash Flow | -80.00K | 28.68K | 22.03M | 6.86M | 24.17M | 22.39M | 21.34M | 31.46M | 8.74M | 509.00K |
| Net Cash Flow | -10.93M | 16.98M | 6.30M | -3.83M | 11.08M | 481.00K | -5.56M | 20.41M | 3.30M | 314.00K |
| Free Cash Flow | -10.85M | -11.71M | -15.14M | -10.77M | -7.25M | -21.91M | -26.90M | -11.04M | -5.43M | -195.00K |